ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer.

Takehiro UemuraTetsuya OguriKen MaenoKazuki SoneAkira TakeuchiSatoshi FukudaEiji KuniiOsamu TakakuwaYoshihiro KanemitsuHirotsugu OhkuboMasaya TakemuraYutaka ItoAkio Niimi

Published in: Cancer chemotherapy and pharmacology (2019)

These results indicate that the SNP538(G > A) in the ABCC11 gene is a potential determinant for S-1 treatment.

Keyphrases

genome wide
emergency department
combination therapy
dna methylation
climate change
copy number
replacement therapy
smoking cessation
drug induced
adverse drug